UnknownNot Applicable

The Two Treatment Methods Compared the Sclerosing Agent Injection and the Rubber Wrapping

China984 participantsStarted 2021-11-01

Plain-language summary

This study is a prospective, multicentre, and randomized-controlled clinical study.The researchers wanted to explore the optimal treatment regimen for soft hemorrhoid within I-Ⅲ degrees by evaluating and comparing the effectiveness, safety and cost effect ratio of sclerosing injection and rubber lap ligation in patients with different internal hemorrhoid scores

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 to 75, men and women;
✓. Patients with clinical symptoms of degree I-Ⅲ internal hemorrhoids confirmed after medical history collection, clinical examination or colonoscopy;
✓. The patient was willing to receive minimally invasive treatment for internal hemorrhoids and sign informed consent by himself or his legal agent.

Exclusion criteria

✕. Age \<18 or age\> 75;
✕. External hemorrhoids or mixed hemorrhoids;
✕. degree Ⅳ internal hemorrhoids
✕. Unsymptomatic internal hemorrhoids
✕. Internal hemorrhoids were combined with complications such as chimerism, thrombosis, ulceration, or infection；
✕. Poor basic conditions can not tolerate endoscopic treatment, such as serious cardiovascular and cerebrovascular diseases, respiratory dysfunction, liver and kidney failure, mental disorders, etc.;
✕. There are other serious diseases involving the rectum and anus, such as anal fistula, perianal infection, anal stenosis, inflammatory bowel disease activity period, colorectal tumors, etc.;
✕. Patients with severe coagulation dysfunction or long-term oral anticoagulant drugs or antiplatelet aggregation drugs without withdrawal;

What they're measuring

recurernce rate

Timeframe: 12 months

Trial details

NCT IDNCT05089500

SponsorRenmin Hospital of Wuhan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

Contact for this trial

Mingkai Chen, M.D

0086-13720330580 kaimingchen@163.com

View on ClinicalTrials.gov More Hemorrhoid trials